Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Tolvaptan Tablets

Approval Number

国药准字H20213153

Company江苏恒瑞医药股份有限公司

Registration Date

March 2, 2021

Drug Information

Generic Name

托伐普坦片

Dosage Form

片剂

Strength

30mg

Drug Type

化学药品

Registration Date

March 2, 2021

Company Information

Applicant Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区黄河路38号

Manufacturing Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区黄河路38号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

托伐普坦片 - NMPA 批准文号 | MedPath